The University Medical Center Freiburg in Freiburg, Germany is the teaching hospital and part of the medical research unit of the University of Freiburg and home to its Faculty of Medicine. The medical center is one of the largest hospitals in Europe.

There are 1,600 beds in Universitätsklinikum Freiburg.

During the past decade, Universitätsklinikum Freiburg conducted 180 clinical trials. In the 10-year time frame, 180 clinical trials started and 77 clinical trials were completed, i.e. on average, 42.8% percent of trials that started reached the finish line to date. In the past 5 years, 80 clinical trials started and 41 clinical trials were completed. i.e. 51.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Freiburg" #1 sponsor was "Eli Lilly and Company" with 14 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 14 trials sponsored, "Janssen Research & Development, LLC" with 11 trials sponsored, "Boehringer Ingelheim" with 10 trials sponsored and "Hoffmann-La Roche" with 10 trials sponsored. Other sponsors include 257 different institutions and companies that sponsored additional 174 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Freiburg" #1 collaborator was "AbbVie" with 6 trials as a collaborator, "Incyte Corporation" with 5 trials as a collaborator, "Hoffmann-La Roche" with 4 trials as a collaborator, "Roche Pharma AG" with 4 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 186 different institutions and companies that were collaborators in the rest 165 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Freiburg" are "Myelodysplastic Syndromes" (9 trials), "Acute Myeloid Leukemia" (8 trials), "Leukemia" (8 trials), "Multiple Myeloma" (8 trials) and "Ovarian Cancer" (6 trials). Many other conditions were trialed in "Universitätsklinikum Freiburg" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Freiburg" are "Drug" (243 trials), "Device" (35 trials), "Biological" (26 trials), "Other" (24 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (53 trials), "Dexamethasone" (8 trials), "Obinutuzumab" (7 trials), "Docetaxel" (6 trials) and "Azacitidine" (5 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Freiburg" are 295 trials for "All" genders, 13 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are 113 active trials in "Universitätsklinikum Freiburg". 2 are not yet recruiting, 60 are recruiting, 49 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 153 completed trials in Universitätsklinikum Freiburg, undefined suspended trials, and 31 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Freiburg, 21 "Phase 1" clinical trials were conducted, 88 "Phase 2" clinical trials and 144 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 23 trials that are defined as “Not Applicable".

Universitätsklinikum Freiburg has several departments that took part in Clinical trials: "Medical Center - University of Freiburg, Eye Hospital" - 14 trials, "Universitatsklinikum Freiburg - Klinik fur Innere Medizin I" - 12 trials, "Heart Center Bad Krozingen" - 11 trials, "Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie" - 8 trials, "Universitats-Herzzentrum Freiburg - Bad Krozingen" - 175 trials, "Universitätsklinikum Freiburg; Klinik für Innere Medizin I; Hämatologie/Onkologie" - 5 trials, "Dept. of Psychiatry, University of Freiburg" - 5 trials, "Medizinische Universitätsklinik III, Abt. Kardiologie und Angiologie" - 5 trials, "Universitätsklinikum Freiburg Klinik für Dermatologie und Venerologie" - 5 trials, "Universitätsklinikum Freiburg, Klinik für Neurologie und Neurophysiologie" - 3 trials, "University Hospital Freiburg, Neurosurgery" - 3 trials, "Institute for Microbiology and Hygiene" - 2 trials, "Neurochirurgische Klinik der Universitat Freiburg" - 2 trials, "Uniklinikum Freiburg Zentrum für Kinder- und Jugendmedizin; Pädiatrische Infektio- u. Rheumatologie" - 2 trials, "Universitätsklinikum Freiburg, Abteilung Pneumologie" - 3 trials, "Universitätsklinikum Freiburg; Klinik für Neuropädiatrie und Muskelerkrankungen" - 3 trials, "Herzzentrum Bad Krozingen, Elektrophysiologie" - 2 trials, "Universitätsklinikum Freiburg, Centrum für Chronische Immundefizienz (CCI) - Paediatric Unit" - 2 trials, "Clinic for Rheumatology and Internal Medicine" - 2 trials, "Universitätsklinikum der Albert-Ludwig-Universität Freiburg, Department Othopädie und Traumatologie" - 2 trials, "Universitätsklinikum Freiburg, Zentrum für Kinder- und Jugendmedizin, Klinik IV: Päd. Hämatologie und Onkologie" - 2 trials, "University of Freiburg - Medical Center - Dept. of Stereotactic and Functional Neurosurgery" - 2 trials, "Universitätsklinikum Freiburg; Medizinische UNI-Klinik; Abt. Innere Medizin - VI Rheumatologie" - 2 trials, "Heart Center, University of Freiburg" - 2 trials, "University Hospital Freiburg, Dep. for Child & Adolescent Psychiatry" - 2 trials